The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in 2013 to more than $262 billion by 2019.
“PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market”, provides strategic analysis of the global biosimilars industry. It discusses key market trends, regulatory requirements in various markets, recent deals activity and trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as India providing in-depth analysis of these markets’ regulatory framework, key domestic players and their biosimilar pipelines, and strategic outlook.
Buy a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=194151 .
While many biologic manufacturers are seeking to slow the entry of biosimilars into the market, GlobalData’s report states that the biosimilars arena is attracting attention from contract manufacturing organizations, such as Lonza and Celltrion, along with contract research organizations, including Quintiles and Paraxel, and multi-industry conglomerates, such as Samsung and LG.
In addition to private ventures, some national governments are targeting the biosimilars market to sustain their domestic pharmaceutical industries. Most significantly, South Korea announced in 2011 that it aims to create approximately 120,000 new jobs in the sector, in a bid to capture 22% of the global biosimilars market by 2020.
What are the drivers of the global biosimilars industry?
Inquire for Discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=194151 .
Reasons to buy
Major points in Table of Contents
1 Table of Contents
3 Market Overview
4 Biosimilar Deals Trends
5 Biosimilars Regulation
6 Biosimilars in the US
7 Biosimilars in Europe
8 Biosimilars in Japan
9 Biosimilars in India
10 Biosimilars in South Korea
11 Biosimilars in China
12 Case Study: Teva Pharmaceutical Industries
13 Strategic Outlook
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Company Name: RnR Market Research
Contact Person: Ritesh Tiwari
Email: Send Email
Phone: 1 888 391 5441
Address:7557 Rambler Road,Suite 727
Country: United States